Norges Bank acquired a new position in Gilead Sciences shares, triggering institutional ownership filing requirements with the SEC.
1 report, 1 independent
Updated Jul 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Norges Bank acquired a new position in Gilead Sciences shares, triggering institutional ownership filing requirements with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Gilead Sciences
American company
-
Norges Bank
central bank of Norway
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Source Capital, Inc. filed required documents with the Securities and Exchange Commission regarding institutional ownership changes.
- The SEC is tracking 13F filings submitted by institutional investors, involving Omnicom Group.
- Novo Nordisk filed required documents with the SEC regarding stock changes on October 22, 2026.
- Kestra Private Wealth Services LLC increased its stake in Chemomab Therapeutics stock, as tracked by an SEC filing.
- Filings detail fund holdings for VGT with the Securities and Exchange Commission.